Lonza L7 hiPSC Reprogramming and hPSC Culture System

Friday, 27 June, 2014 | Supplied by: Capsugel Australia Pty Ltd


Lonza introduces its L7 hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modelling, drug development and regenerative medicine. The offering includes tools to simplify and streamline the stem-cell culturing and reprogramming workflow. The culture system supports the generation of reproducible, clinically relevant data as a solid basis for more efficient drug development and accelerated progress in regenerative medicine.

The stem-cell reprogramming and culture system includes seven key components that are aligned and function as a robust workflow: primary cells, including disease phentoypes; Nucleofector technology; hPSC reprogramming kits; hPSC medium; hPSC matrix; hPC passaging solution; hPSC cryosolution.

The culture system is claimed to be the only complete solution for the generation of induced pluripotent stem-cells (iPSCs), the maintenance of human embryonic stem-cells (hESCs) and iPSCs under defined, xeno-free conditions. It allows for every other day feeding and supports long-term culture and maintenance of hPSCs. The system thus provides a seamless transition from the lab bench to clinical development applications.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...

Azure Biosystems Ao Microplate Reader

The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...

Navinci Naveni Plex isPLA multiplex solution

The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd